HBK Investments’s SCP & CO Healthcare Acquisition Company Warrant SHACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-195,000
Closed -$113K 981
2021
Q3
$113K Sell
195,000
-45,000
-19% -$31.8K ﹤0.01% 616
2021
Q2
$204K Sell
240,000
-60,000
-20% -$38.4K ﹤0.01% 667
2021
Q1
$178K Buy
+300,000
New +$184K ﹤0.01% 719

Other funds holding SHACW

HBK Investments's SHACW Position: Q3 2022 in Review

HBK Investments sold out of SCP & CO Healthcare Acquisition Company Warrant (SHACW) in Q3 2022, closing a stake of 195,000 shares — an estimated $16K sold.

HBK Investments first reported a position in SHACW in Q4 2021 and held it in 3 quarters. The position peaked at $107K in Q4 2021. 53 funds tracked by Wall St. Rank hold SHACW as of Q3 2022.

  • HBK Investments reported no remaining SCP & CO Healthcare Acquisition Company Warrant position as of Q3 2022 after selling out during the quarter.
  • HBK Investments sold 195,000 SCP & CO Healthcare Acquisition Company Warrant shares in Q3 2022, an estimated $16K.
  • HBK Investments first reported a position in SCP & CO Healthcare Acquisition Company Warrant in Q4 2021 and held it in 3 quarters.
  • HBK Investments's SCP & CO Healthcare Acquisition Company Warrant position peaked at $107K in Q4 2021.
  • 53 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Warrant as of Q3 2022.

Based on HBK Investments's 13F filing for Q3 2022, filed 14 Nov 2022.